Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of Clinical Medicine|April 12, 2022
A Simple Prognostic Score for Critical COVID-19 Derived from Patients without Comorbidities Performs Well in Unselected PatientsVasiliki E Georgakopoulou, Nikolaos I Vlachogiannis, Dimitrios Basoulis, et al.
Shock (Augusta, Ga.)|March 22, 2024
HEPARIN-BINDING PROTEIN LEVELS PREDICT UNFAVORABLE OUTCOME IN COVID-19 PNEUMONIA: A POST HOC ANALYSIS OF THE SAVE TRIALEvdoxia Kyriazopoulou, George N Dalekos, Symeon Metallidis, et al.
Antibiotics (Basel, Switzerland)|September 28, 2024
Assessment of De-Escalation of Empirical Antimicrobial Therapy in Medical Wards with Recognized Prevalence of Multi-Drug-Resistant Pathogens: A Multicenter Prospective Cohort Study in Non-ICU Patients with Microbiologically Documented InfectionVasiliki Rapti, Garyfallia Poulakou, Anastasia Mousouli, et al.
Experimental and Therapeutic Medicine|October 24, 2022
Acute hepatitis and liver injury in hospitalized patients with COVID‑19 infectionVasiliki Epameinondas Georgakopoulou, Triada Bali, Magdalini Adamantou, et al.
Cell Reports. Medicine|January 3, 2026
A randomized controlled trial of precision bezlotoxumab treatment for Clostridioides difficile infectionChristos Psarrakis, Nikolaos-Renatos Tziolos, Vicky Matzarakis, et al.
NEJM Evidence|August 4, 2023
Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant OrganismsKeith S Kaye, Dror Marchaim, Visanu Thamlikitkul, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 6, 2026
The Impact of Colistin MIC on Clinical Failure and Mortality: Insights from the OVERCOME TrialJason M Pogue, Michael J Rybak, Jacinda C Abdul-Mutakabbir, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2025
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative PathogensMariya Huralska, Jason M Pogue, Michael Rybak, et al.
International Journal of Antimicrobial Agents|December 8, 2024
Anakinra efficacy in COVID-19 pneumonia guided by soluble urokinase plasminogen activator receptor: Association with the inflammatory burden of the hostEvdoxia Kyriazopoulou, Karolina Akinosoglou, Eleni Florou, et al.
Intensive Care Medicine Experimental|June 29, 2025
29-mRNA host response signatures for classification of bacterial infection, viral infection and disease progression in COVID-19 pneumonia: a post hoc analysis of the SAVE-MORE randomized clinical trialEvdoxia Kyriazopoulou, Antigone Kotsaki, Asimina Safarika, et al.
Pageof 7